Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume 26, Issue 2, Pages 159-167
Publisher
Springer Nature
Online
2008-01-25
DOI
10.1007/s10637-008-9112-9

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.